ProQR Therapeutics N.V (NASDAQ:PRQR) price on Thursday, July 03, rose 2.35% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $2.18.
A look at the stock’s price movement, the close in the last trading session was $2.13, moving within a range at $2.1067 and $2.18. The beta value (5-Year monthly) was 0.308. Turning to its 52-week performance, $4.62 and $1.07 were the 52-week high and 52-week low respectively. Overall, PRQR moved 22.47% over the past month.
ProQR Therapeutics N.V’s market cap currently stands at around $229.36 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PRQR is a 50% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in Hold category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 4 recommend PRQR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PRQR’s current price about 10.94% and 22.49% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 66.95, while 7-day volatility ratio is 9.12% and 6.40% in the 30-day chart. Further, ProQR Therapeutics N.V (PRQR) has a beta value of 0.43. Analysts have given the company’s stock an average 52-week price target of $3.75, forecast between a low of $2 and high of $5. Looking at the price targets, the low is 8.26% off current price level while to achieve the yearly target high, price needs to move -129.36%. Nonetheless, investors will most likely welcome a -72.02% jump to $3.75 which is the analysts’ median price.
If we refocus on ProQR Therapeutics N.V (NASDAQ:PRQR), historical trading data shows that trading volumes averaged 0.48 over the past 10 days and 472.20K over the past 3 months. The company’s latest data on shares outstanding shows there are 105.34 million shares.
The 31.36% of ProQR Therapeutics N.V’s shares are in the hands of company insiders while institutional holders own 38.66% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.64 million on 2025-06-13, giving us a short ratio of 2.05. The data shows that as of 2025-06-13 short interest in ProQR Therapeutics N.V (PRQR) stood at 86.0 of shares outstanding, with shares short rising to 0.57 million registered in 2025-05-15. Current price change has pushed the stock 32.12% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PRQR stock continues to rise going into the next quarter.
